Efficacy and Safety of Ivabradine in an Elderly Patient with Heart Failure with Reduced Ejection Fraction
Authors:
- 27 January 2021
- journal article
- research article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 41 (2) , 193-196
Abstract
No abstract availableFunding Information
- Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (19K08498)
This publication has 12 references indexed in Scilit:
- Efficacy and Safety of Ivabradine in Japanese Patients With Chronic Heart Failure ― J-SHIFT Study ―Circulation Journal, 2019
- 9‐Year Trend in the Management of Acute Heart Failure in Japan: A Report From the National Consortium of Acute Heart Failure RegistriesJournal of the American Heart Association, 2018
- Hypotensive Drugs and Syncope Due to Orthostatic Hypotension in Older Adults with Dementia (Syncope and Dementia Study)Journal of the American Geriatrics Society, 2018
- Autonomic Dysfunction is Associated with Cardiac Remodelling in Heart Failure PatientsESC Heart Failure, 2017
- Neurophysiology of HCN channels: From cellular functions to multiple regulationsProgress in Neurobiology, 2014
- Orthostatic Hypotension and Incident Heart Failure in Community-Dwelling Older AdultsThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2013
- Effects on Outcomes of Heart Rate Reduction by Ivabradine in Patients With Congestive Heart Failure: Is There an Influence of Beta-Blocker Dose?JACC, 2012
- Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled studyThe Lancet, 2010
- Favourable Effects of Heart Rate Reduction with Intravenous Administration of Ivabradine in Patients with Advanced Heart FailureEuropean Journal of Heart Failure, 2008
- Impending Epidemic Future Projection of Heart Failure in Japan to the Year 2055Circulation Journal, 2008